You are here

  • Home
  • Archive
  • Volume 59, Issue 1
  • Genetic characterisation of sarcomatoid carcinomas reveals multiple novel actionable mutations and identifies KRAS mutation as a biomarker of poor prognosis

Citation Tools

Article menu
Download PDFPDF
Cancer genetics
Original research
Genetic characterisation of sarcomatoid carcinomas reveals multiple novel actionable mutations and identifies KRAS mutation as a biomarker of poor prognosis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ding Y, Shao Y, Na C, et al
Genetic characterisation of sarcomatoid carcinomas reveals multiple novel actionable mutations and identifies KRAS mutation as a biomarker of poor prognosis
Journal of Medical Genetics 2022;59:10-17.